Biospecifics Technologies (BSTC US)

Health Care • United States

BioSpecifics Technologies Corp. is a biopharmaceutical company. The Company developed and licensed injectable collagenase for the treatment of Dupuytren's disease, Peyronie's disease, and adhesive capsulitis (frozen shoulder).

Refresh

Request Primer

No publications yet

No AI primers are available right now. Create one using Smartkarma AI.

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00